Indian Institute of Technology (IIT), Guwahati, Assam, in collaboration with the Center for Medical Biotechnology of the Maharshi Dayanand University (MDU), Rohtak, Haryana, India find that Vectormune ND induced very strong clinical protection against the genotype XIII NDV strain from India with significant reduction of the re-excretion of the challenge virus.